De Geer, Karl
Mascianica, Katarzyna
Naess, Karin
Sardh, Eliane
Lindstrand, Anna
Björck, Erik
Funding for this research was provided by:
Karolinska Institute
Article History
Received: 24 January 2023
Accepted: 12 September 2023
First Online: 26 September 2023
Declarations
:
: No ethical approval required.
: KDG: None. KM: None. KN: None. ES: Receiver of research grant from Alnylam Pharmaceuticals Inc. AL: Member of the European Reference Network on Rare Congenital Malformations and Rare Intellectual Disability ERN-ITHACA [EU Framework Partnership Agreement ID: 3HP-HP-FPA ERN-01-2016/739516]. EB: Receiver of research grant from Novartis Sverige AB.
: Written informed consent was obtained from the patient for publication of this case report.